AASLD News

AASLD welcomes momentum in elevating lifelong liver health as a global public health priority The American Association for the Study of Liver Diseases (AASLD) welcomes the World Health Organization (WHO) Executive Board’s recent decision to advance proposals to expand the global definition of noncommunicable diseases (NCDs) to formally include liver diseases and inherited bleeding disorders. This

ALEXANDRIA, Virginia — February 3, 2026 – The American Association for the Study of Liver Diseases (AASLD) invites applications for the next Editor-in-Chief or co-Editor-in-Chief team of Hepatology Communications, its open-access, peer-reviewed journal dedicated to advancing discovery and innovation in liver science. Founded in 2017, Hepatology Communications is a monthly, online-only, open access

Dear AASLD Community, It’s truly an honor to begin this year serving as President of the American Association for the Study of Liver Diseases (AASLD). I step into this role with deep gratitude for the community that defines AASLD, respect for the leadership that preceded me, and a strong sense of responsibility for the work ahead. AASLD has been a professional home to me since I was a medical

Alexandria, VA — The American Association for the Study of Liver Diseases (AASLD) is pleased to announce the leadership of its 2026 Governing Board. As champions in advancing liver science, care, and education, these distinguished leaders from leading academic, clinical, and research institutions across the country. The Governing Board will guide AASLD’s strategic vision and organizational mission

The American Association for the Study of Liver Diseases (AASLD) expresses deep concern over the 2025–2030 Dietary Guidelines for Americans (DGA), released jointly by the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA), which remove specific, evidence-based guidance on alcohol consumption. The updated guidelines advise individuals to consume less

On January 7, 2026, the Department of Health and Human Services (HHS) and the Department of Agriculture (USDA) released updated Dietary Guidelines for Americans (DGA) for 2025-2030, removing any specific guidance on alcohol consumption. The updated guidelines instead advise that people should “consume less alcohol for better overall health” and “limit beverages,” without recommending clear limits

In 2025, AASLD advanced science, strengthened education, shaped public policy, expanded global engagement, and brought the hepatology community together in powerful ways. These accomplishments reflect the collective leadership, expertise, and dedication of our members, volunteers, and professional staff. Explore the resources below to learn more about the impact achieved this year and the people

Adult Liver Transplantation: Candidate Evaluation and Adult Liver Transplantation: Diagnosis and Post-Transplant Management of Non-Graft-Related Complications ALEXANDRIA, VA — The American Association for the Study of Liver Diseases (AASLD) and American Society of Transplantation (AST) are pleased to announce two new Practice Guidelines published in HEPATOLOGY and Liver Transplantation, AASLD’s

ALEXANDRIA, Virginia — The American Association for the Study of Liver Diseases (AASLD) is pleased to announce the appointment of Naga Chalasani, MD, FAASLD, of Indiana University School of Medicine, and Laura E. Nagy, PhD, FAASLD, of Cleveland Clinic, as the next Co-Editors-in-Chief of HEPATOLOGY. HEPATOLOGY, the premier publication in the field of liver disease, publishes original, peer-reviewed

The American Association for the Study of Liver Diseases (AASLD) and its undersigned partner organizations, American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA), American Society for Gastrointestinal Endoscopy (ASGE), Infectious Diseases Society of America (IDSA), and North American Society for Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN)

New guidance provides clinicians with practical, evidence-based criteria for patient selection, comorbidity management, and monitoring the safety and effectiveness of semaglutide therapy for metabolic dysfunction-associated steatohepatitis (MASH). The American Association for the Study of Liver Diseases (AASLD) announces the updated Practice Guidance on Semaglutide therapy for Metabolic

The American Association for the Study of Liver Diseases (AASLD) acknowledges the recent market withdrawal of obeticholic acid (OCA) for the treatment of primary biliary cholangitis (PBC) by Intercept Pharmaceuticals. OCA has served as a second-line therapeutic option for patients with an inadequate response to ursodeoxycholic acid, and its withdrawal marks a significant change in the PBC

The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) are pleased to announce a new Practice Guideline on Treatment of Chronic Hepatitis B published in HEPATOLOGY, the premier publication in the field of liver disease. Chronic hepatitis B (CHB) is a dynamic disease that progresses through multiple phases. The new guideline provides

AASLD proudly recognizes the Department of Veterans Affairs (VA) Hepatitis Innovation Team (HIT) and the HIT collaborating offices with VA ALEXANDRIA, Virginia — Each year, the American Association for the Study of Liver Diseases (AASLD) presents its most prestigious awards to recognize exceptional leadership, mentorship, service, and advocacy across the liver community. AASLD proudly announces